Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model

Journal of Liposome Research

Volumn 21, Issue 2, 2011, Pages 134-140

  Nagle, Amrita ^a   Goyal, Amit K ^b   Kesarla, Rajesh ^b   Murthy, Rayasa R ^b  

^a M S UNIVERSITY OF BARODA   (India)

^b ISF COLLEGE OF PHARMACY   (India)

Author keywords

carbopol 934p; liposome; menthol; Methotrexate; penetration enhancer; psoriasis; vesicular gel

Indexed keywords

CARBOPOL 934; LIPOSOME; MENTHOL; METHOTREXATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG RETENTION; DRUG STABILITY; GEL; MALE; NONHUMAN; PARAKERATOSIS; PRIORITY JOURNAL; PSORIASIS; RAT;

ADMINISTRATION, TOPICAL; ANIMALS; DERMATOLOGIC AGENTS; DIFFUSION CHAMBERS, CULTURE; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; DRUG SYNERGISM; GELS; HUMANS; IMMUNODIFFUSION; LIPOSOMES; MALE; MENTHOL; METHOTREXATE; PARAKERATOSIS; PERMEABILITY; PSORIASIS; RATS; RATS, WISTAR; SKIN; SKIN ABSORPTION; TISSUE CULTURE TECHNIQUES;

EID: 79956149590     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2010.492476     Document Type: Article

References (28)

1. Ali, M. F., Salah, M., Rafea, M., Saleh, N. (2008). Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization, and laser targeting. Med Sci Monit 14:166-174.
2. Barker, J. N. (1991). The pathophysiology of psoriasis. Lancet 338:227-230.
3. Bleicher, P. A. (1993). T lymphocytes in psoriasis. J Invest Dermatol 101:695-700.
4. Brady, S. P. (2004). Parakeratosis. J Am Acad Dermatol 50:77-84. (Pubitemid 38095656)
5. Brown, W. R., Rogozinski, T. T., Ramsay, C. A. (2006). Anthralin and tar with UVB increases epidermal cell proliferation in asebia mice. Clin Exp Dermatol 13:248-251.
6. Danilenko, D. M. (2008). Animal models of human disease: preclinical models of psoriasis. Vet Pathol 45:563-575.
7. Dawn, A., Yosipovitch, G. (2006). Treating itch in psoriasis. Dermatol Nurs 18:227-233.
8. Fujii, M., Takeda, Y., Yoshida, M., Utoguchi, N., Matsumoto, M., Watanabe, Y. (2003). Comparison of skin permeation enhancement by 3-l-menthoxypropane-1,2-diol and l-menthol: the permeation of indomethacin and antipyrine through yucatan micropig skin and changes in infrared spectra and X-ray diffraction patterns of stratum corneum. Int J Pharm 258:217-223. (Pubitemid 36712885)
9. Hadgraft, J., Guy, R. H. (2003). Feasibility assessment in topical and transdermal delivery: mathematical models and in vitro studies. In: Hadgraft, J., Guy, R. H. (Eds.), Transdermal drug delivery: development issues and research initiatives, vol 123 (pp 1-24). New York: Marcel Dekker.
10. Ho, H-O., Chen, L-C., Lin, H-M., Sheu, M-T. (1998). Penetration enhancement by menthol combined with a solubilization effect in a mixed solvent system. J Contr Rel 51(2-3):301-311. (Pubitemid 28252882)
11. Jain, A. K., Thomas, N. S., Panchagnula, R. (2002). Transdermal drug delivery of imipramine hydrochloride, effect of terpenes. J Contr Rel 79:93-101. (Pubitemid 34168193)
12. Lakshmi, P. K., Devi, G. S., Bhaskaran, S., Sacchidanand, S. (2007). Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies. Ind J Dermatol Venereol Leprol 73:157-161. (Pubitemid 46918508)
13. Leigh, I. M., Pulfordf, K. A., Ramaekers, F. C. S., Lane, E. B. (1985). Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation. Br J Dermatol 113:53-64. (Pubitemid 15006911)
14. Liu, Y., Ye, X., Feng, X., Zhou, G., Rong, Z., Fang, C., et al. (2005). Menthol facilitates the skin analgesic effect of tetracaine gel. Int J Pharm 305(1-2):31-36. (Pubitemid 41562215)
15. Maghraby, E., Gemel, M. M., Adrian, C. W., Brain, W. B. (2006). Can drug-bearing liposomes penetrate intact skin? J Pharm Pharmacol 58:415-429.
16. Nakaguna, H., Kambara, T., Yamamoto, T. (1995). Rat ultravoilet ray B photodermatitis: an experimental model of psoriasis vulgaris. Int J Exp Pathol 76:65-73.
17. Pershing, L. K., Lambert, L. D., Knutson, K. (1990). Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm Res 7:170-175.
18. Sasaki, H., Kojima, M., Mori, Y., Nakamura, J., Shibasaki, J. (1991). Enhancing effect of pyrrolidone derivatives on transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indomethacin, and flurbiprofen. J Pharm Sci 80:533-538.
19. Shokria, J., Nokhodchi, A., Dashbolaghia, A., Hassan-Zadeha, D., Ghafourianb, T., Barzegar Jalali, M. (2001). The effect of surfactants on the skin penetration of diazepam. Int J Pharm 228:99-107. (Pubitemid 32905369)
20. Sinha, V. R., Kaur, M. P. (2000). Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 26:1131-1140.
21. Skelly, J. P., Shah, V. P., Maibach, H. I., Guy, R. H., Wester, R. C., Flynn, G., et al. (1987). FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies: relevance to bioavailability and bioequivalence. Pharm Res 4:265-267. (Pubitemid 17110406)
22. Spearman, R. I. C., Hardy, J. A. (1977). Ultrastructure of the contrasting types of keretinization seen in the tail epidermis of the laboratory mouse Mus musculens. Arch Dermatol Res 258:33-40. (Pubitemid 8071669)
23. Stratis, A., Pasparakis, M., Rupec, R. A., Markur, D., Hartmann, K., Scharffetter-Kochanek, K., et al. (2006). Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasislike skin inflammation. J Clin Invest 116:2094-2104. (Pubitemid 44162318)
24. Sutton, L., Swinehart, J. M., Cato, A., Kaplan, A. S. (2001). A clinical study to determine the efficacy and safety of 1% methotrexate/azone (MAZ) gel applied topically once-daily in patients with psoriasis vulgaris. Int J Dermatol 40:464-467. (Pubitemid 32982303)
25. Tekade, R. K., Dutta, T., Tyagi, A., Bharti, A. C., Das, B. C., Jain, N. K. (2008). Surface-engineered dendrimers for dual drug delivery: A receptor upregulation and enhanced cancer targeting strategy. J Drug Targ 16:758-772.
26. Vanaja, K., Shobha Rani, R. H., Sacchidananda, S. (2008). Formulation and clinical evaluation of ultradeformable liposomes in the topical treatment of psoriasis. Clin Res Regul Aff 25:41-52. (Pubitemid 351329013)
27. Weinstein, G. D., McCullough, J. L., Olsen, E. (1989). Topical MTX therapy for psoriasis. Arch Dermatol 125:227-230.
28. Wrench, R., Britten, A. (1975). Evaluation of coal tar fractions for use in psoriasiform diseases using the mouse tail test. III. High boiling tar oil acids. Br J Dermatol 93:67-73.